caffeine has been researched along with Amnesia-Memory Loss in 6 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study was designed to assess the role of caffeine on fertility parameters in testicular and epididymal tissues of scopolamine-induced model of amnesia in rats." | 7.91 | Caffeine improves sperm quality, modulates steroidogenic enzyme activities, restore testosterone levels and prevent oxidative damage in testicular and epididymal tissues of scopolamine-induced rat model of amnesia. ( Akomolafe, SF; Oboh, G; Ogunsuyi, OB; Olasehinde, TA; Oyeleye, SI, 2019) |
| "Cilostazol (CSZ) has been shown to be a new treatment for cognitive impairment with limited efficacy." | 5.72 | Advancing combination treatment with cilostazol and caffeine for Alzheimer's disease in high fat-high fructose-STZ induced model of amnesia. ( Ahmed, AM; El-Mokhtar, MA; Farghaly, HSM; Gomaa, AA; Hemida, FK, 2022) |
| " Active compounds exhibited an inverted U-shaped dose-response curve." | 5.27 | Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam. ( Butler, DE; L'Italien, YJ; Marriott, JG; Nordin, IC; Poschel, PH; Zweisler, L, 1984) |
| "This study was designed to assess the role of caffeine on fertility parameters in testicular and epididymal tissues of scopolamine-induced model of amnesia in rats." | 3.91 | Caffeine improves sperm quality, modulates steroidogenic enzyme activities, restore testosterone levels and prevent oxidative damage in testicular and epididymal tissues of scopolamine-induced rat model of amnesia. ( Akomolafe, SF; Oboh, G; Ogunsuyi, OB; Olasehinde, TA; Oyeleye, SI, 2019) |
| "The effects of a variety of adenosine A1 and A2 antagonists on N6-((R)-phenylisopropyl)adenosine (R-PIA)- and scopolamine-induced amnesias were investigated in rodents in order to clarify the role of adenosine receptors in learning and memory." | 3.68 | Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance. ( Fuse, E; Ichikawa, S; Ishii, A; Kobayashi, H; Nakamura, J; Nonaka, H; Shimada, J; Shiozaki, S; Suzuki, F, 1993) |
| "Cilostazol (CSZ) has been shown to be a new treatment for cognitive impairment with limited efficacy." | 1.72 | Advancing combination treatment with cilostazol and caffeine for Alzheimer's disease in high fat-high fructose-STZ induced model of amnesia. ( Ahmed, AM; El-Mokhtar, MA; Farghaly, HSM; Gomaa, AA; Hemida, FK, 2022) |
| " Active compounds exhibited an inverted U-shaped dose-response curve." | 1.27 | Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam. ( Butler, DE; L'Italien, YJ; Marriott, JG; Nordin, IC; Poschel, PH; Zweisler, L, 1984) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Butler, DE | 1 |
| Nordin, IC | 1 |
| L'Italien, YJ | 1 |
| Zweisler, L | 1 |
| Poschel, PH | 1 |
| Marriott, JG | 1 |
| Suzuki, F | 1 |
| Shimada, J | 1 |
| Shiozaki, S | 1 |
| Ichikawa, S | 1 |
| Ishii, A | 1 |
| Nakamura, J | 1 |
| Nonaka, H | 1 |
| Kobayashi, H | 1 |
| Fuse, E | 1 |
| Gomaa, AA | 1 |
| Farghaly, HSM | 1 |
| Ahmed, AM | 1 |
| El-Mokhtar, MA | 1 |
| Hemida, FK | 1 |
| Akomolafe, SF | 1 |
| Olasehinde, TA | 1 |
| Ogunsuyi, OB | 1 |
| Oyeleye, SI | 1 |
| Oboh, G | 1 |
| Singh, N | 1 |
| Parle, M | 1 |
| Dall'Igna, OP | 1 |
| Fett, P | 1 |
| Gomes, MW | 1 |
| Souza, DO | 1 |
| Cunha, RA | 1 |
| Lara, DR | 1 |
6 other studies available for caffeine and Amnesia-Memory Loss
| Article | Year |
|---|---|
Amnesia-reversal activity of a series of N-[(disubstituted-amino)alkyl] -2-oxo-1-pyrrolidineacetamides, including pramiracetam.
Topics: Amnesia; Animals; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroshock; Huma | 1984 |
Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance.
Topics: Adenosine; Amnesia; Animals; Avoidance Learning; Diuretics; Male; Mice; Motor Activity; Phenylisopro | 1993 |
Advancing combination treatment with cilostazol and caffeine for Alzheimer's disease in high fat-high fructose-STZ induced model of amnesia.
Topics: Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Animals; Caffeine; Cilostazol; Diabetes Mellitus, | 2022 |
Caffeine improves sperm quality, modulates steroidogenic enzyme activities, restore testosterone levels and prevent oxidative damage in testicular and epididymal tissues of scopolamine-induced rat model of amnesia.
Topics: 17-Hydroxysteroid Dehydrogenases; Amnesia; Animals; Caffeine; Disease Models, Animal; Epididymis; Li | 2019 |
Sildenafil improves acquisition and retention of memory in mice.
Topics: Alprazolam; Amnesia; Animals; Caffeine; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; | 2003 |
Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice.
Topics: Adenosine A2 Receptor Antagonists; Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Animals; Avoid | 2007 |